COLUMBIA, Md., Aug. 18 /PRNewswire-FirstCall/ — Martek
Biosciences Corporation (Nasdaq:
MATK) announced today that it intends to release the results of
its third quarter of fiscal 2010 on Wednesday, September 1, 2010,
at approximately 4:00 p.m. Eastern Time (ET). At 4:45 p.m. ET
Martek will conduct a conference call to discuss these results with
investors. All interested parties may listen to the call live
via webcast by visiting Martek’s web site at http://investors.martek.com.
An archived webcast of the conference call will be available on
the Martek’s website for thirty days. In addition, a recorded
playback of the call will be available for one week and can be
accessed by calling 800-633-8284 or 402-977-9140 and entering pass
code 21479068.
Martek Biosciences Corporation is a leader in the innovation,
development, production and sales of high-value products from
microbial sources that promote health and wellness through
nutrition. The company is the world’s leading provider of algal DHA
omega-3 with its flagship product, life’sDHA™, a sustainable
and vegetarian source of algal DHA omega-3 important for brain,
heart and eye health throughout life, for use in foods, beverages,
infant formula, and supplements. The company also produces
life’sARA™ (arachidonic acid), an omega-6 fatty acid, for use
in infant formula and growing up milks. Additionally, Martek’s
subsidiary, Amerifit Brands, develops, markets and distributes
branded consumer health and wellness products in major mass, club,
drug, grocery and specialty stores and holds leading brand
positions in all of its key product categories. For more
information on Martek Biosciences, visit http://www.martek.com/. For a
complete list of life’sDHA™ or life’sARA™ products,
visit
